H.P. Acthar® Gel ( DrugBank: - )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 14 | Chronic inflammatory demyelinating polyneuropathy | 1 |
14. Chronic inflammatory demyelinating polyneuropathy
Clinical trials : 167 / Drugs : 158 - (DrugBank : 38) / Drug target genes : 13 - Drug target pathways : 23
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT02574962 (ClinicalTrials.gov) | August 2015 | 30/8/2015 | Pilot Study of Acthar® Gel in Chronic Inflammatory Demyelinating Neuropathy | Pilot Study of Acthar® Gel in Chronic Inflammatory Demyelinating Neuropathy | Chronic Inflammatory Demyelinating Polyneuropathy | Drug: H.P. Acthar® Gel | Mamatha Pasnoor, MD | Mallinckrodt | Withdrawn | 18 Years | N/A | Both | 0 | Phase 2 | United States |